Introduction
The role of insulin resistance in the pathophysiology of type 2 diabetes mellitus (T2DM) and the metabolic syndrome are well established (35, 37), and exploration of the mechanisms leading to diminished insulin sensitivity is a field of active research.
Activation of the tissue renin-angiotensin-system (RAS) has been linked to increased production of reactive oxygen species (ROS) through activation of the NADPH oxidase enzymatic complex in numerous tissues, including skeletal muscle (5, 35) . Excessive oxidative stress may result in impairment of intracellular insulin signaling, constituting a potential pathway by which RAAS activation induces insulin resistance (5, 14, 31) .
There is growing interest in the role of mineralocorticoids in the pathogenesis of insulin resistance. Mineralocorticoids participate in the regulation of blood pressure, water, sodium and potassium homeostasis through interaction with the mineralocorticoid receptor (MR) located in target epithelial cells, translocation to the nucleus, and triggering of specific genomic actions (10) . However, mineralocorticoids also exert acute actions in multiple non-epithelial tissues, which appear to be independent of gene transcription (12) . These non-genomic actions are particularly relevant in cardiovascular disease (CVD), as they can result in hypertrophy, endothelial dysfunction (4, 17) , inflammation (30), fibrosis, apoptosis and cardiovascular remodeling (27) . Recently, aldosterone has been reported to suppress insulin metabolic signaling in vascular smooth muscle cells via an oxidative stress mediated mechanism (14) . This raises the possibility that aldosterone, like angiotensin II (Ang II) can suppress insulin mediated glucose uptake in various tissues (5, 35) .
Available studies in humans have shown, independent of other components of CMS, an association between increased plasma levels of aldosterone and presence of insulin resistance in the CMS (6, 18) . In addition, aldosterone excess in patients with primary aldosteronism is related to impaired glucose homeostasis (11) as well as insulin resistance (9) . Likewise, euglycemic hyperinsulinemia results in increased aldosterone production in response to Ang II in an animal model (25) , and in healthy humans (32).
These detrimental effects have been related to proinflammatory effects exerted by mineralocorticoids (18). However, the impact of signaling through the MR on glucose metabolism in ex vivo skeletal muscle has not been investigated.
The transgenic TG(mRen2)27 rat (Ren2), which harbors the mouse renin gene, is an experimental model of excessive tissue local renin-angiotensin system (RAS) activity, which through paracrine adrenal effects leads to increased plasma deoxycorticosterone (DOC), 18-hydroxycorticosterone and aldosterone levels, as well as whole body and skeletal muscle insulin resistance (5, 24, 26, 29) . Previous studies from our laboratory have demonstrated that AT 1 R blockade, and ROS scavenging improves whole body glucose tolerance and skeletal muscle insulin-stimulated glucose transport (5, 35) . Since mineralocorticoids promote oxidative stress in cardiovascular tissue (5), we sought to investigate the impact of in vivo MR blockade with low dose spironolactone (SP) on systemic insulin sensitivity, parameters of skeletal muscle insulin metabolic signaling and insulin-stimulated glucose uptake in relation to NADPH oxidase activity/ROS in young insulin resistant Ren2 rats.
Page 4 of 29

Methods
Animals and treatments:
All animal procedures were approved by the University of Missouri animal care and use committees and housed in accordance with NIH guidelines. Ren2 (6-7 weeks of age) and age matched SD littermates were randomly assigned to untreated (Ren2-C and SD-C, respectively), or spironolactone treated (Ren2-Sp and SD-Sp) paradigms. Ren2-Sp and SD-Sp animals were implanted with a 5mg timed release spironolactone or placebo pellet subcutaneously (Innovative Research of America Sarasota, Florida) for 21 days.
Pellets were placed, under anesthesia, via a super scapular incision closed with permanent suture.
Systolic Blood Pressure (SBP) and Body Weight:
Restraint conditioning was initiated before blood pressure measurements. SBP was measured in triplicate, on separate occasions throughout the day, using the tail-cuff method (Harvard Systems, Student Oscillometric Recorder) prior to initiation of treatment and on days 19 or 20 prior to sacrifice at 21 days (34, 35). Total body weight was obtained prior to initiation of treatment and at time of sacrifice.
Intraperitoneal glucose tolerance test (IPGTT)
Animals were fasted overnight before the experiment. On day 21, the rats were weighed and anesthetized with nembutal (35 mg/kg intraperitoneally). The femoral artery was carefully dissected and canulated with a 27-gauge angiocath. A 200 µl blood sample was drawn for insulin and glucose measurements. A dose of dextrose (50% solution, 1 g/kg body wt) was injected intraperitoneally, and blood was drawn at 15, 30, 45 and 60 min for insulin and glucose determination. Serum glucose concentrations were determined by means of the glucose oxidase method, and serum was separated analyzed for insulin (ELISA kit; Linco, St. Charles, MO). Insulin Resistance Index was calculated as the product of areas under the glucose and insulin curves (AUC Glucose X AUC Insulin ) as previously described (13) .
Oxidative stress:
NADPH Oxidase Activity: NADPH oxidase activity was determined in plasma membrane fractions as previously described (5, 33, 34, 35) . Aliquots of soleus muscle membrane and cytosolic fractions (12.5-100 mg proteins) were incubated with NADPH (100mM) at 37° C. NADPH oxidase activity was determined by measuring the conversion of Radical Detector (Cayman Chemical) in the absence and presence of NADPH inhibitor diphenylene iodonium sulfate (dpi) (500µM) using spectrophotometric (450nm) techniques.
NADPH Oxidase subunit immunostaining:
Harvested soleus muscle tissue was immersed and fixed in 3% paraformaldehyde and prepared as previously described (36).
Blocks were sectioned and incubated with 1:100 dilution of primary antibodies in 10 fold diluted blocking agent, and third/fourth sections were washed and kept in the blocker.
Over the course of 48 hours, a fifth, sixth, and seventh section was incubated with 1:100 goat gp91 phox (NOX2) (Santa Cruz), 1:100 goat p22 phox , and 1:100 and p47 phox antibody (Upstate Cell Signaling) respectively, in 10 fold diluted blocker. Other sections were incubated with 1:300 Alexa-fluor rabbit anti-goat 647 (Molecular Probe, Eugene, OR) for 4 hours and examined using a laser confocal scanning microscope, images captured by Reactive Oxygen Species formation: Levels of reactive oxygen species in skeletal muscle using isolated soleus tissue sections were measured by chemiluminescense.
Tissue sections were homogenized in sucrose buffer (250 mM sucrose, 0.5 mM EDTA, 50 mM HEPES, protease inhibitor tablet, pH 7.5) using a glass/glass homogenizer.
Homogenates were centrifuged 1500 rcf x 10 min at 4 o C. Supernatants (whole homogenate) were then removed and placed on ice. Whole homogenate (100 uL) was added to 1.4 mL of 50 mM phosphate (KH 2 PO 4 ) buffer (150 mM sucrose, 1mM EGTA, 5 uM lucigenin, 100 uM NADPH, pH 7.0) in dark-adapt counting vials. After dark adaptation for 1 hour, samples were counted every 30 seconds for 10 min on a scintillation counter and the last 5 minutes were averaged. Samples were then normalized to total protein in the whole homogenate. Values are expressed as counts per minute per milligram of protein (cpm/mg).
Glucose transport:
Page 7 of 29 2-deoxyglucose transport was measured in isolated soleus strips incubated in the presence or absence of a maximally effective dose of insulin (100 nM) as previously described (5, 29) . Soleus muscles were dissected out of anesthetized rats, which had been fasted overnight. The soleus muscle was carefully dissected into longitudinal strips (<40 mg) and incubated for 45 min in 4 mL of pre-incubation buffer that had been brought to 37 o C and aerated with 95% O 2 -5% CO 2 gas. Pre-incubation buffer consisted of 8 mM glucose, 32 mM mannitol, and 0.1% BSA in modified Kreb's-Hensleit Buffer (KHB).
After additional incubation for 15 min with or without insulin, muscles were transferred 
Quantification of in IRS, Akt, and GLUT4 in Soleus Muscle:
After sacrificing the animals, a strip of soleus muscle was fixed in 3%
paraformaldehyde and processed for immunostaining as previously described (33 on which donkey anti mouse was used. After 4 hours the sections were mounted with mowiol, the images were captured and the signals were analyzed as previously described (33).
Statistics:
All results are presented as means ± standard error. Analysis of variance (ANOVA) with Fisher's Least Significant Differences (LSD) and Dunnett's multiple post-hoc testing were performed and unpaired t test, as appropriate.
Results
Systolic Blood Pressure (SBP):
There were no significant differences among the study groups with respect to age or weight. At initiation of treatment (6-7 weeks of age), SBP were higher in Ren2-C (145.8±1.7 mmHg) compared with SD controls (129.8±1.1 mmHg, p <0.05) (Fig 1) . At the end of the treatment period (9 to 10 wks of age) there was a significant increase in 
Whole body insulin sensitivity studies:
Insulin sensitivity was analyzed during an IPGTT, in which both serum insulin and glucose concentrations were determined and their respective AUC were calculated. Soleus tissue ROS levels were higher in Ren2 controls (1805±343 cpm/mg) compared to the placebo treated SD group (701±175 cpm/mg, p <0.05). There was a similar trend to lower ROS activity observed in the Ren2-Sp treated rat muscles (1099±320 cpm/mg, p>0.05) (Fig 3D) . 4-HNE immunostaining, a surrogate for ROSmediated membrane lipid peroxidation, was increased in soleus muscle of Ren2-C (240.4±16.0 average grey scale intensities) compared to SD-C (100.0±22.0 average grey (Fig 3E) .
Insulin-stimulated glucose uptake measurements:
Skeletal muscle 2-DOG uptake response to insulin was measured in the absence and presence of maximally effective doses of insulin (100 nM) (Fig 4) . 
IRS, Akt, and GLUT4 immunostaining:
Consistent with glucose uptake studies there were decreases in IRS-1, Akt, and GLUT4 immunostaining in the soleus muscle of Ren2 rats, which improved significantly with low dose spironolactone treatment. Total and Tyrosine (Tyr) 941 phosphorylated IRS-1 were reduced in the Ren2-C (28.0±2.9 and 24.3±2.9 average grey scale intensities, respectively) compared to SD-C (39.6±5.5 and 44.5±3.9 average grey scale intensities, respectively; p<0.05) (Fig 5A) . There were improvements in total and TryIRS-1 in the average grey scale intensities, p<0.05) (Fig 5C) .
Discussion
The present investigation explored the effect of a very low, non-blood pressure lowering, dose of the MR blocker spironolactone on oxidative stress and insulinstimulated glucose transport in skeletal muscle from a rodent model of increased tissue RAS activation and elevated aldosterone levels. In vivo treatment of young Ren2 rats with low dose of spironolactone for 3 weeks improved systemic insulin sensitivity reduced soleus muscle NADPH oxidase activity/ROS production and improved skeletal muscle parameters of insulin metabolic signaling, as well as insulin-stimulated glucose transport. That these beneficial effects were independent of changes in systolic blood pressure suggest direct MR mediated effects on skeletal tissue. Thus, this is the first study that demonstrates that MR antagonism directly affects skeletal muscle insulin metabolic signaling in conjunction with reductions in oxidative stress.
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As previously observed (5), oxidative stress as measured by skeletal muscle NADPH oxidase activity, ROS production, and membrane lipid peroxidation, were increased in Ren2 compared to control SD rats. These MR mediated effects on skeletal muscle oxidative stress and insulin metabolic signaling are similar to previously observed effects of AT 1 R activation (5, 35). Our laboratory has previously observed that in vivo treatment of young Ren2 rats with a ROS scavenger or AT 1 R blocker results in decreases in skeletal muscle NADPH oxidase activity and ROS generation, which was associated with improved systemic and skeletal muscle insulin sensitivity (5, 35) . Collectively, these observations suggest that both Ang II and aldosterone reduce skeletal muscle insulin metabolic signaling, in part, through increases in oxidative stress.
NADPH oxidase is a highly regulated membrane-bound enzyme complex that There are several potential mechanisms by which MR activation may reduce insulin metabolic signaling in skeletal muscle tissue. One potential mechanism for aldosterone-induced insulin resistance appears to be the transcriptional down regulation of the insulin receptor, in addition to impairment of the intracellular insulin signaling (8).
Glucocorticoid response elements (GRE) have been identified in the promoter of the insulin receptor gene (19) and interactions between activated MR and GRE may result in a negative transcriptional effect of the aldosterone over the insulin receptor gene (8) .
Aldosterone also activates glucocorticoid receptors in extra-renal tissue (38), which has direct negative effects on insulin metabolic signaling (23) . A recent report suggests that A limitation of our study is the absence of measurements of plasma spironolactone concentrations, which would have assessed the absorption from the pellets. However, use of spironolactone pellets is supported in the available literature, and it is estimated that the absorption is adequate to elicit biological activity (1, 7) . Also, previous studies in our laboratory have demonstrated that in cultured myocytes (L6 cells)
Ang II is linked to increased activity of NADPH oxidase, production of ROS as well as impairment of intracellular insulin signaling mediated through IRS-1 and Akt pathways (35), which were reversed by blocking AT 1 R and ROS scavenging. However, this study did not specifically include measurements of mineralocorticoids, and thus we cannot conclude about the impact of these strategies on mineralocorticoid activity in cultured myocytes.
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Our data support the hypothesis that MR antagonism can reduce oxidative stress and improve insulin sensitivity in a rodent model of activated RAAS activity and insulin resistance. These effects were obtained in skeletal muscle, a classical target tissue of insulin action using low-dose SP, and were independent of changes in systolic blood pressure. These data add to previous observations that increased oxidative stress leads to impaired insulin sensitivity in skeletal muscle, and that RAAS interruption using AT 1 R blockade and/or Ang converting enzyme inhibition attenuates these changes (5, 35 
